A scientific journal revealed the results of research conducted by a number of scientists with the aim of studying the effects of some drugs against the emerging corona virus.
The specialized scientific journal “scitechdaily” published the results of a study conducted by Israeli researchers to confirm the effectiveness of the previous treatment for infection with the emerging corona virus by giving low doses of aspirin.
Aspirin is a very effective and low-cost drug that is found in most homes and pharmacies and is used in the treatment of a wide range of ailments from the heart to headache.
Studies have shown that aspirin, in addition to its known anti-inflammatory effects, can modulate innate and adaptive immune responses, helping the human immune system fight some viral infections.
With this information in mind, the Israeli researchers hypothesized that prior treatment of the infection with a low dose of aspirin (75 mg) may have a potential beneficial effect against the emerging corona virus.
A joint team from Leumit Health Services, Bar-Ilan University and Barzilai Medical Center conducted an observational epidemiological study, using data from the health services provided.
Their findings were published recently in the journal “FEBS” after analyzing more than 10 thousand test cases of “Covid 19” patients in Israel.
The results showed a good response among the study sample, as the results indicated a 29% lower probability of infection compared to people who were not given doses of aspirin.
And people who were treated with aspirin were less associated with the risk of infection “Covid 19” than those who were not treated with it.